MedPath

Effects of 3% diquafosol sodium ophthalmic solution on visual function in patient with dry eye wearing contact lens.

Not Applicable
Conditions
dry eye
Registration Number
JPRN-UMIN000010975
Lead Sponsor
Minamiaoyama Eye Clinic Tokyo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1) History of administered diquafosol sodium ophthalmic solution and/or rebamipide ophthalmic solution within one week before start of study. 2) Anatomically and/or functionally abnormal eyelid. (ex. eyelid closure abnormality) 3) History of ophthalmic surgery (including laser therapy) within 3 months before start of study. 4) History of occluding punctum. (ex. punctal plug or a punctal closing surgery) 5) Presence of a hypersensitivity to drugs scheduled to be used. (ex. diquafosol sodium, fluorescein, oxybuprocaine hydrochloride) 6) Presence of any other medical concern that may affect the accurate efficacy assessment or ensuring safety.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath